{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:10:16Z","timestamp":1772118616387,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"NIH\/NCI","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Follicular lymphoma (FL) is the most common subtype of indolent non\u2010Hodgkin lymphoma. It has been hypothesized that chronic hepatitis C virus (HCV) infection stimulates\n                    <jats:italic>IGH\u2010BCL2<\/jats:italic>\n                    clone proliferation, leading to development of FL. Furthermore, regression of FL after antiviral treatment without chemotherapy has been reported in HCV\u2010infected patients. To clarify the relationship between HCV and FL, we compared the prevalence of\n                    <jats:italic>IGH\u2010BCL2<\/jats:italic>\n                    translocation and other clinicopathologic characteristics between HCV\u2010infected and HCV\u2010uninfected FL patients and determined the impact of HCV eradication on the oncologic outcomes of HCV\u2010infected FL patients. The study included HCV\u2010infected patients (cases) with FL seen at our institution during 2004\u20102018. Cases were matched with HCV\u2010uninfected FL patients (controls) according to year of lymphoma diagnosis, sex, and hepatitis B serology. We studied 19 cases and 57 controls. More cases than controls had splenic involvement of FL (26% vs 5%,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.02), higher histologic grade (grade 3 in 56% vs 24%,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.01), absent or weak CD10 expression (42% vs 11%,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.005), and absent BCL2 expression (33% vs 4%,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.004). Compared to controls, cases had a lower rate of detection of\n                    <jats:italic>IGH\u2010BCL2<\/jats:italic>\n                    translocation (31% vs 68%,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.02). Finally, cases with a sustained virologic response (virologic cure of HCV) had a better 10\u2010year overall survival rate than did cases not treated with antivirals or controls (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.001). In conclusion, HCV\u2010infected patients with FL have unique clinicopathologic characteristics including improved overall survival with HCV eradication. The pathogenesis of FL in HCV\u2010infected patients seems unrelated to antiapoptotic effect of\n                    <jats:italic>IGH\u2010BCL2<\/jats:italic>\n                    rearrangement.\n                  <\/jats:p>","DOI":"10.1002\/hon.2731","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T14:56:33Z","timestamp":1584716193000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathologic characteristics of follicular lymphoma in hepatitis C virus\u2010infected patients"],"prefix":"10.1002","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-1587","authenticated-orcid":false,"given":"Jeff","family":"Hosry","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Samaniego","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Angelidakis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrys A.","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health The University of Texas MD Anderson Cancer Center  Houston Texas USA"},{"name":"Department of Gastroenterology, Hepatology and Nutrition The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21403"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.011"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.018"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29845"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1513288"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-714667"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-041863"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-198580"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24937"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2910"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02573.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.6.1555"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx635"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.02.004"},{"issue":"12","key":"e_1_2_9_18_1","first-page":"2257","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T\u2010cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED\u20102 concerted action BMH4\u2010CT98\u20103936","volume":"17","author":"JJMV D","year":"2013","journal-title":"Leukemia"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23138"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30372"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31110"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01081.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.06.005"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00118-3"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12913"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<85::AID-GCC11>3.0.CO;2-9"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404426"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04086.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.042531"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168682"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.06.007"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12892"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0383-2"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hon.2731","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:17:41Z","timestamp":1693808261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/hon.2731"],"URL":"https:\/\/doi.org\/10.1002\/hon.2731","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/HON.2731\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v3\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2731\/v3\/decision1","asserted-by":"object"}]},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"2019-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}